Niranjan Andhalkar

He is the Director – Director – Strategic Management & Planning at ProRelix Research. His visionary leader with 17+ years of experience in clinical research, pharmaceuticals, CROs, and healthcare IT. Known for driving business growth, strategic collaborations, and innovation, he has successfully built and scaled organizations in the global clinical research ecosystem. With academic expertise in Biotechnology, Clinical Research, and an MBA in Operations Management, he combines scientific knowledge with strong business strategy to create impactful and sustainable healthcare ventures.

Best ePRO Clinical Trials Mobile App | ProCTTH

March 30, 2026August 16, 2023 by Niranjan Andhalkar

ProCTTH is the Best ePRO Clinical Trials Mobile App which is the ultimate solution for efficient and seamless data collection in clinical trials. With user-friendly features and advanced functionalities, it…

By Niranjan Andhalkar

What are eCOA, ePRO & patient centricity in clinical trials?

March 30, 2026May 18, 2023 by Niranjan Andhalkar

What are eCOA, ePRO and Patient Centricity in Clinical Trials?

eCOA and ePRO refer to electronic methods of collecting patient-reported outcomes and clinical data in clinical trials, respectively. These technologies allow for real-time data collection and improved accuracy, as well…

By Niranjan Andhalkar

Current Challenges in Clinical Trial Patient Recruitment and Enrollment

March 30, 2026May 2, 2023 by Niranjan Andhalkar

Current Challenges in Clinical Trial Patient Recruitment and Enrollment, including Patient Engagement to avoid dropouts. Introduction: Understanding the Basics of Clinical Trial Patient Recruitment and Enrollment Clinical trial patient recruitment…

By Niranjan Andhalkar

US FDA Guidance on Decentralized Clinical Trials

March 30, 2026February 27, 2023 by Niranjan Andhalkar

Decentralized, virtual, siteless, remote-all buzzwords in the clinical trial arena that are gaining increased traction in the post-pandemic landscape. Although started during the COVID-19 pandemic as a means of patient…

By Niranjan Andhalkar